Workflow
scenario-based DCF modeling
icon
搜索文档
Amgen's Strategic Path - Navigating Patent Expiries With Promising New Therapies
Seeking Alpha· 2025-06-06 14:31
With a background as an RN and an MBA, Stephen analyzes healthcare and tech stocks by combining clinical insight with rigorous valuation methods. He specializes in scenario-based DCF modeling, sensitivity analysis, and Monte Carlo simulations to uncover asymmetric risk-reward. His focus is on translating complex science and market dynamics into actionable investment theses. His influences include Superforecasting and Fooled by Randomness.Stay up to date with Stephen's latest thoughts and investment insights ...
Sanofi: Finding Value In The Wake Of Itepekimab's Disappointment
Seeking Alpha· 2025-05-31 21:15
With a background as an RN and an MBA, Stephen analyzes healthcare and tech stocks by combining clinical insight with rigorous valuation methods. He specializes in scenario-based DCF modeling, sensitivity analysis, and Monte Carlo simulations to uncover asymmetric risk-reward. His focus is on translating complex science and market dynamics into actionable investment theses. His influences include Superforecasting and Fooled by Randomness.Stay up to date with Stephen's latest thoughts and investment insights ...
MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition
Seeking Alpha· 2025-05-27 12:02
分析师背景 - 分析师Stephen拥有注册护士和MBA背景 结合临床洞察力与严谨的估值方法分析医疗保健和科技股 [1] - 擅长基于情景的DCF建模 敏感性分析和蒙特卡洛模拟 以发现不对称的风险回报机会 [1] - 专注于将复杂的科学和市场动态转化为可操作的投资论点 [1] 分析方法 - 采用概率性分析方法 而非绝对确定性预测 反映作者个人观点 [3] - 分析基于作者独立研究 不代表任何机构立场 [4] 内容性质 - 文章旨在提供信息内容 不作为详尽分析或个性化投资建议 [3] - 不包含具体的买卖持有等投资推荐 [3] - 读者需自行验证信息并独立研究 [3]
Hims & Hers: Growth, Strategic Partnerships, And Operational Leverage (Upgrade)
Seeking Alpha· 2025-05-16 17:00
With a background as an RN and an MBA, Stephen analyzes healthcare and tech stocks by combining clinical insight with rigorous valuation methods. He specializes in scenario-based DCF modeling, sensitivity analysis, and Monte Carlo simulations to uncover asymmetric risk-reward. His focus is on translating complex science and market dynamics into actionable investment theses. His influences include Superforecasting and Fooled by Randomness.Stay up to date with Stephen's latest thoughts and investment insights ...
CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)
Seeking Alpha· 2025-05-08 20:36
With a background as an RN and an MBA, Stephen analyzes healthcare and tech stocks by combining clinical insight with rigorous valuation methods. He specializes in scenario-based DCF modeling, sensitivity analysis, and Monte Carlo simulations to uncover asymmetric risk-reward. His focus is on translating complex science and market dynamics into actionable investment theses. His influences include Superforecasting and Fooled by Randomness.Stay up to date with Stephen's latest thoughts and investment insights ...
Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns
Seeking Alpha· 2025-05-07 00:48
分析师背景 - 分析师拥有注册护士和MBA背景 擅长结合临床洞察与估值方法分析医疗保健和科技股 [1] - 专长包括基于情景的DCF建模 敏感性分析和蒙特卡洛模拟 以发现不对称风险回报机会 [1] - 专注于将复杂科学和市场动态转化为可操作的投资观点 [1] 分析方法论 - 采用概率性分析框架 而非绝对确定性预测 观点基于情景分析和敏感性测试 [3] - 分析过程包含科学验证环节 但可能存在无意错误 建议读者独立核实信息 [3] 免责声明 - 文章内容仅代表作者个人观点 不构成任何投资建议 [2] - 作者未持有相关公司股票 未来72小时内无交易计划 [2] - 与提及公司无商业关系 未获得除平台外的任何报酬 [2]